Variant report
Variant | nsv553225 |
---|---|
Chromosome Location | chr11:5188827-5199222 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:33)
- CpG islands (count:0)
- Chromatin interactive region (count:16)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:33 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr11:5193260-5193372 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr11:5194443-5194536 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr11:5199045-5199305 | K562 | blood: | n/a | n/a |
4 | BHLHE40 | chr11:5193299-5193453 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr11:5188482-5188830 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr11:5189572-5189685 | K562 | blood: | n/a | chr11:5189660-5189671 chr11:5189660-5189673 |
7 | CHD2 | chr11:5195669-5195693 | GM12878 | blood: | n/a | n/a |
8 | E2F4 | chr11:5195343-5195706 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | EP300 | chr11:5193168-5193440 | K562 | blood: | n/a | n/a |
10 | EP300 | chr11:5193277-5193345 | K562 | blood: | n/a | n/a |
11 | GATA2 | chr11:5193089-5193482 | K562 | blood: | n/a | chr11:5193396-5193408 |
12 | IRF1 | chr11:5195603-5195739 | K562 | blood: | n/a | n/a |
13 | IRF1 | chr11:5189337-5189476 | K562 | blood: | n/a | n/a |
14 | IRF3 | chr11:5195651-5195661 | GM12878 | blood: | n/a | n/a |
15 | JUN | chr11:5194475-5194479 | K562 | blood: | n/a | n/a |
16 | KAP1 | chr11:5190483-5190886 | K562 | blood: | n/a | n/a |
17 | MYC | chr11:5193269-5193405 | K562 | blood: | n/a | n/a |
18 | NR2F2 | chr11:5192960-5193507 | K562 | blood: | n/a | n/a |
19 | NR2F2 | chr11:5193109-5193474 | K562 | blood: | n/a | n/a |
20 | POLR2A | chr11:5192931-5193030 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr11:5195116-5195176 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | POLR2A | chr11:5193131-5193405 | K562 | blood: | n/a | n/a |
23 | POLR2A | chr11:5192160-5192182 | A549 | lung: | n/a | n/a |
24 | POLR2A | chr11:5191980-5192158 | A549 | lung: | n/a | n/a |
25 | POLR2A | chr11:5192379-5192412 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | RCOR1 | chr11:5193156-5193450 | K562 | blood: | n/a | n/a |
27 | RCOR1 | chr11:5195428-5195650 | K562 | blood: | n/a | n/a |
28 | TAL1 | chr11:5193068-5193487 | K562 | blood: | n/a | chr11:5193212-5193221 |
29 | TBL1XR1 | chr11:5193247-5193421 | K562 | blood: | n/a | n/a |
30 | TEAD4 | chr11:5193087-5193521 | K562 | blood: | n/a | n/a |
31 | TEAD4 | chr11:5193077-5193496 | K562 | blood: | n/a | n/a |
32 | ZNF143 | chr11:5192655-5192677 | K562 | blood: | n/a | n/a |
33 | ZNF274 | chr11:5192595-5193989 | K562 | blood: | n/a | n/a |
No data |
(count:16 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:5192167..5196032-chr11:5198178..5201494,6 | K562 | blood: | |
2 | chr11:5191942..5195830-chr11:5198178..5202032,4 | K562 | blood: | |
3 | 11:5181580-5190487..11:5700314-5707362 | GM12878 | blood: | |
4 | 11:5181580-5190487..11:5714465-5718134 | K562 | blood: | |
5 | chr11:5188106..5190567-chr11:5193129..5195928,3 | K562 | blood: | |
6 | chr11:5188106..5190567-chr11:5193129..5195928,3 | K562 | blood: | |
7 | chr11:5151076..5153190-chr11:5193820..5196178,2 | K562 | blood: | |
8 | chr11:5192167..5196032-chr11:5198178..5201494,6 | K562 | blood: | |
9 | chr11:5174124..5177497-chr11:5196224..5198159,3 | K562 | blood: | |
10 | 11:5181580-5190487..11:5250847-5268367 | Hela-S3 | cervix: | |
11 | chr11:5191942..5195830-chr11:5198178..5202032,4 | K562 | blood: | |
12 | chr11:5188285..5189927-chr11:5190428..5192790,2 | K562 | blood: | |
13 | 11:5181580-5190487..11:5533869-5541626 | K562 | blood: | |
14 | 11:5181580-5190487..11:5527719-5533869 | GM12878 | blood: | |
15 | chr11:5172907..5175854-chr11:5188403..5191895,3 | K562 | blood: | |
16 | chr11:5176895..5179770-chr11:5188054..5190408,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR51A1P | TF binding region |
ENSG00000260629 | chromatin interactions |
ENSG00000223609 | chromatin interactions |
ENSG00000229988 | chromatin interactions |
ENSG00000176752 | chromatin interactions |
ENSG00000132256 | chromatin interactions |
ENSG00000182070 | chromatin interactions |
ENSG00000132274 | chromatin interactions |
ENSG00000175518 | chromatin interactions |
ENSG00000176748 | chromatin interactions |
ENSG00000175520 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10742552 | chr11:5188827-5188828 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs10734485 | chr11:5188844-5188845 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs575328149 | chr11:5188848-5188849 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
4 | rs575234657 | chr11:5188870-5188871 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
5 | rs557508574 | chr11:5188914-5188915 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
6 | rs573028289 | chr11:5188917-5188918 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
7 | rs540122881 | chr11:5188928-5188929 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
8 | rs562038206 | chr11:5188933-5188934 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
9 | rs10742553 | chr11:5188936-5188937 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs371127348 | chr11:5188956-5188957 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
11 | rs139029524 | chr11:5188960-5188961 | Enhancers Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
12 | rs74051378 | chr11:5189056-5189057 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs551532466 | chr11:5189062-5189063 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
14 | rs189765705 | chr11:5189083-5189084 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
15 | rs75982646 | chr11:5189101-5189102 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
16 | rs57552480 | chr11:5189117-5189118 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs546928963 | chr11:5189147-5189148 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
18 | rs568746696 | chr11:5189170-5189171 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
19 | rs10742555 | chr11:5189202-5189203 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs550560964 | chr11:5189250-5189251 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
21 | rs568941396 | chr11:5189262-5189263 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
22 | rs138191905 | chr11:5189367-5189368 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
23 | rs115885209 | chr11:5189369-5189370 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
24 | rs57911787 | chr11:5189398-5189399 | Weak transcription Enhancers | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs144019642 | chr11:5189415-5189416 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
26 | rs555312849 | chr11:5189416-5189417 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
27 | rs201652530 | chr11:5189457-5189458 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
28 | rs386750119 | chr11:5189458-5189459 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
29 | rs60636854 | chr11:5189460-5189461 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
30 | rs573875160 | chr11:5189554-5189555 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
31 | rs556570694 | chr11:5189558-5189559 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
32 | rs56381892 | chr11:5189604-5189605 | Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs201058515 | chr11:5189612-5189613 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
34 | rs199828586 | chr11:5189623-5189624 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
35 | rs61491854 | chr11:5189627-5189628 | Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs57430332 | chr11:5189630-5189631 | Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs57138324 | chr11:5189682-5189683 | Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs60603509 | chr11:5189687-5189688 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
39 | rs540814628 | chr11:5189688-5189689 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
40 | rs559807891 | chr11:5189731-5189732 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
41 | rs374007829 | chr11:5189735-5189736 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
42 | rs7481293 | chr11:5189743-5189744 | Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs529524638 | chr11:5189760-5189761 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
44 | rs12279380 | chr11:5189764-5189765 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
45 | rs550896378 | chr11:5189771-5189772 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
46 | rs78546573 | chr11:5189781-5189782 | Weak transcription | Chromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
47 | rs74051384 | chr11:5189899-5189900 | Weak transcription | Chromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs551416138 | chr11:5189930-5189931 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
49 | rs61060114 | chr11:5189995-5189996 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
50 | rs10160444 | chr11:5190030-5190031 | Weak transcription | Chromatin interactive region | 8 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5186600-5192200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr11:5187400-5189000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr11:5187800-5189400 | Enhancers | K562 | blood |
4 | chr11:5188600-5189000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr11:5189400-5191600 | Weak transcription | K562 | blood |
6 | chr11:5191600-5193200 | Enhancers | K562 | blood |
7 | chr11:5192200-5192400 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr11:5193200-5193600 | Flanking Active TSS | K562 | blood |
9 | chr11:5193600-5194000 | Enhancers | K562 | blood |
10 | chr11:5194000-5199000 | Weak transcription | K562 | blood |
11 | chr11:5199000-5200000 | Enhancers | K562 | blood |